Liver News and Research

RSS

If global efforts to prevent HIV/AIDS are to work long term, they must avoid suspicions of being unfair

Johns Hopkins infectious disease specialists who have spent more than two decades leading efforts to combat HIV and AIDS worldwide are warning that limited international relief supplies of antiretroviral therapies currently being distributed in Africa, Asia and the Caribbean will not get to those who can least afford to pay for them.

28 Jun 2005

Research into a protein for treatment of cancer brings prestigious award

Although primarily known for its roles in obesity and reproduction, the protein leptin has been linked to breast cancer in a study which is the recipient of the prestigious Susan G. Komen Foundation award.

28 Jun 2005

New low-cost technology that allows thousands of tumor slices to be screened side-by-side

Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have devised a new low-cost technology that allows thousands of tumor slices to be screened side-by-side, an improvement over current and more expensive methods that can analyze only several hundred tumors at once.

27 Jun 2005

Metabasis and Merck collaborate to develop new treatment for diabetes, hyperlipidemia and obesity

Metabasis Therapeutics and Merck announced today that they have formed a collaboration to research, develop and commercialize novel small molecule therapeutics with potential to treat several diseases, including type II diabetes, hyperlipidemia and obesity, by activation of an enzyme in the liver called AMP-activated Protein Kinase (AMPK).

27 Jun 2005

New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

Leading medical experts from throughout the UK will be gathering in Edinburgh today and tomorrow (21-22 April 2004) to arrive at a consensus on how best to treat and manage the 'silent epidemic' of hepatitis C - a virus which is estimated to be carried by over 400,000 people in the UK and which continues to spread globally, as the majority of carriers do not realise they have been infected.

21 Jun 2005

Researchers isolate substance most responsible for the tissue damage that follows initial spinal cord injury

Purdue University researchers may have isolated the substance most responsible for the tissue damage that follows initial spinal cord injury, a discovery that could also improve treatments for a host of other neurodegenerative conditions.

21 Jun 2005

Radiofrequency ablation (RFA) is an effective, longlasting treatment for small kidney tumors in selected patients

Massachusetts General Hospital (MGH) researchers have shown that radiofrequency ablation (RFA) - a minimally invasive way of destroying tissue - is an effective, longlasting treatment for small kidney tumors in selected patients.

20 Jun 2005

Researchers use novel cocktail of cells to coax muscle tissue to develop its own vascular network

For years, a major obstacle has dashed the hopes of creating "replacement parts" for the human body: the lack of an internal, nourishing blood system in engineered tissues. Without it, thicker tissues can't thrive, which has confined tissue engineering's practical application to thin skin, which can recruit blood vessels from underlying tissue.

20 Jun 2005

Stem cells grown in lab mirror normal developmental steps

Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.

20 Jun 2005

Findings may help scientists improve the existing vaccine for yellow fever

In one of the first molecular studies of the human antibody response to yellow fever, Howard Hughes Medical Institute (HHMI) researchers and their colleagues have found the crucial bit of virus that people's immune systems need to spot and quash this often-fatal re-emerging disease.

16 Jun 2005

Columbia University launches multi-year campaign to support stem cell researc

Columbia University Medical Center (CUMC) has announced that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university’s groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells.

16 Jun 2005

Promising new tuberculosis drug enters clinical trial

A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced this week.

15 Jun 2005

'Hazardous' drinking and drug use are much less severe but much more common than dependence

Research has found that individuals with alcohol and drug dependencies have a greater occurrence of injuries, hypertension, HIV, hepatitis, acid-related peptic disorders, liver cirrhosis, depression, anxiety disorders, and major psychoses.

14 Jun 2005

Causes, consequences and clinical implications of alcohol-related brain shrinkage

Previous studies have demonstrated that the brains of alcoholics are smaller, lighter and "shrunken" when compared to nonalcoholic brains.

14 Jun 2005

Viagra helps children with heart-lung condition achieve improved quality of life

Viagra, a drug originally developed to treat heart disease, and now more commonly used to treat impotence, may also help children with a serious heart-lung condition to walk further and breathe more easily.

14 Jun 2005

When it comes to alcohol problems British doctors come second to publicans and bar staff

A British Medical Association chief says that as many as one in 15 British doctors has had a problem with alcohol or drugs.

14 Jun 2005

When in Russia, drink vodka

Drinking the local beer has landed some 461 Russians in hospital with Hepatitis A and Tver Governor Dmitry Zelenin fully expects that number to rise over the next few days.

13 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Type 2 diabetes may be significantly delayed or prevented through medication that takes the load off of the body's delicate insulin-producing cells, according to a study released today by researchers at the Keck School of Medicine of the University of Southern California.

12 Jun 2005

Genetic variations predispose Mexican Americans to insulin resistance

Although numerous studies have shown that low-grade inflammation is linked to heart disease and diabetes, more recent studies have shown that inflammation plays a role in insulin resistance, a syndrome that leads to diabetes and heart disease and affects about one in four adults in the United States.

12 Jun 2005

Liver News and Research

If global efforts to prevent HIV/AIDS are to work long term, they must avoid suspicions of being unfair

Research into a protein for treatment of cancer brings prestigious award

New low-cost technology that allows thousands of tumor slices to be screened side-by-side

Metabasis and Merck collaborate to develop new treatment for diabetes, hyperlipidemia and obesity

New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

Researchers isolate substance most responsible for the tissue damage that follows initial spinal cord injury

Radiofrequency ablation (RFA) is an effective, longlasting treatment for small kidney tumors in selected patients

Researchers use novel cocktail of cells to coax muscle tissue to develop its own vascular network

Stem cells grown in lab mirror normal developmental steps

Findings may help scientists improve the existing vaccine for yellow fever

Columbia University launches multi-year campaign to support stem cell researc

Promising new tuberculosis drug enters clinical trial

'Hazardous' drinking and drug use are much less severe but much more common than dependence

Causes, consequences and clinical implications of alcohol-related brain shrinkage

Viagra helps children with heart-lung condition achieve improved quality of life

When it comes to alcohol problems British doctors come second to publicans and bar staff

When in Russia, drink vodka

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Genetic variations predispose Mexican Americans to insulin resistance

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News